Addressing the malaria drug resistance challenge using flow cytometry to discover new antimalarials

Addressing the malaria drug resistance challenge using flow cytometry to discover new antimalarials Discovery of novel 1H-imidazol-2-yl-pyrimidine-4,6-diamines as potential antimalarials From a cytotoxic agent to the discovery of a novel antimalarial agent Antiplasmodial activities of 4-aminoquinoline–statine compounds Discovery of Potent Small-Molecule Inhibitors of Multidrug-Resistant Plasmodium falciparum Using a Novel Miniaturized High-Throughput Luciferase-Based Assay Identification of Fast-Acting 2,6-Disubstituted Imidazopyridines That Are Efficacious in the in Vivo Humanized Plasmodium falciparum NODscidIL2Rγ^null Mouse Model of Malaria Application of multi-component reactions to antimalarial drug discovery. Part 1: Parallel synthesis and antiplasmodial activity of new 4-aminoquinoline Ugi adducts Antimalarial activity of 2,6-dibenzylidenecyclohexanone derivatives Discovery of Carbohybrid-Based 2-Aminopyrimidine Analogues As a New Class of Rapid-Acting Antimalarial Agents Using Image-Based Cytological Profiling Assay Potent 4-aminopiperidine based antimalarial agents